Literature DB >> 25759106

Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention.

Alfonso Jurado-Román1, Felipe Hernández-Hernández2, Julio García-Tejada2, Carolina Granda-Nistal2, Javier Molina2, Maite Velázquez2, Agustín Albarrán2, Juan Tascón2.   

Abstract

To investigate the role of hydration to prevent contrast-induced nephropathy (CIN) in patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention (PPCI), we prospectively included 408 consecutive patients who were randomly assigned to receive either hydration with isotonic saline (1 ml/kg/h since the beginning of the procedure and for 24 hours after it: NS+ group) or not (NS- group). All patients received an iso-osmolar nonionic contrast medium. The primary end point was the development of CIN: ≥25% or ≥0.5 mg/dl increase in serum creatinine within 3 days after the procedure. CIN was observed in 14% of patients: 21% in the NS- group and 11% in the NS+ group (p=0.016). CIN was significantly associated with death (15.2% vs 2.8%; p<0.0001) and need for dialysis (13.4% vs 0%; p<0.0001). In multivariate analysis, the only predictors of CIN were hydration (OR=0.29 [0.14 to 0.66]; p=0.003) and the hemoglobin before the procedure (OR=0.69 [0.59 to 0.88]; p<0.0001). In conclusion, intravenous saline hydration during PPCI reduced the risk of CIN to 48%. Patients with CIN had increased mortality and need for dialysis. Given the higher incidence of CIN in emergent procedures, and its morbidity and mortality, preventive hydration should be mandatory in them unless contraindicated.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25759106     DOI: 10.1016/j.amjcard.2015.02.004

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  21 in total

1.  No prophylaxis is non-inferior and cost-saving to prophylactic intravenous hydration in preventing contrast-induced nephropathy on requiring iodinated contrast material administration.

Authors:  Akira Sato; Tomoya Hoshi; Kazutaka Aonuma
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

2.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Clin Exp Nephrol       Date:  2020-01       Impact factor: 2.801

3.  Serum osmolarity as a potential predictor for contrast-induced nephropathy following elective coronary angiography.

Authors:  Mehmet Kanbay; Dimitrie Siriopol; Elif Ozdogan; Baris Afsar; Lale A Ertuglu; Mihaela Grigore; Alan A Sag; Masanari Kuwabara; Miguel A Lanaspa; Alberto Ortiz; Richard J Johnson; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2020-02-01       Impact factor: 2.370

Review 4.  Prevention of Contrast and Radiation Injury During Coronary Angiography and Percutaneous Coronary Intervention.

Authors:  Arash Ehteshami Afshar; Puja B Parikh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-03-22

5.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Jpn J Radiol       Date:  2020-01       Impact factor: 2.374

6.  Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization.

Authors:  Yanming Fan; Qingmin Wei; Junna Cai; Yongtang Shi; Youliang Zhang; Limei Yao; Xiaogang Wang; Shupo Lin; Yilin Li; Jing Lv; Bin Zhou; Ruijuan Du
Journal:  Heart Vessels       Date:  2016-02-13       Impact factor: 2.037

Review 7.  Understanding and preventing contrast-induced acute kidney injury.

Authors:  Michael Fähling; Erdmann Seeliger; Andreas Patzak; Pontus B Persson
Journal:  Nat Rev Nephrol       Date:  2017-01-31       Impact factor: 28.314

8.  Maintaining a National Acute Kidney Injury Risk Prediction Model to Support Local Quality Benchmarking.

Authors:  Sharon E Davis; Jeremiah R Brown; Chad Dorn; Dax Westerman; Richard J Solomon; Michael E Matheny
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2022-08-12

9.  Prognostic significance of renal dysfunction and its change pattern on outcomes in patients with acute coronary syndrome treated with emergent percutaneous coronary intervention.

Authors:  Kenichiro Otsuka; Kenei Shimada; Hisashi Katayama; Haruo Nakamura; Hirotoshi Ishikawa; Hisateru Takeda; Kohei Fujimoto; Noriaki Kasayuki; Minoru Yoshiyama
Journal:  Heart Vessels       Date:  2018-11-01       Impact factor: 2.037

10.  Comparison of Different Hydration Strategies in Patients with Very Low-Risk Profiles of Contrast-Induced Nephropathy.

Authors:  Shuai Miao; Zheng-Kai Xue; Ya-Ru Zhang; Hao Zhang; Jing-Jin Che; Tong Liu; Hua-Yue Tao; Guangping Li; Kang-Yin Chen
Journal:  Med Sci Monit       Date:  2021-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.